Related Experiment Video
Updated: Aug 22, 2025

06:37
Immunolabelling Myofiber Degeneration in Muscle Biopsies
Published on: December 5, 2019
8.9K
Macroglossia in rapidly progressive inclusion body myositis
Yoshimune Yamasaki1, Akihiro Mukaino2, Satoshi Yamashita1
1Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Summary
Inclusion body myositis, a rare muscle disease, can present with macroglossia (enlarged tongue). This case study suggests macroglossia may indicate treatment effectiveness in Inclusion body myositis patients.
Area of Science:
- Neurology
- Immunology
- Pathology
Background:
- Inclusion body myositis (IBM) is a challenging muscle disease with inflammatory and degenerative aspects.
- Macroglossia is typically associated with amyloid light chain amyloidosis, not IBM.
Observation:
- A female patient with pathologically confirmed IBM developed progressive dysphagia, gait issues, and macroglossia.
- Muscle and tongue biopsies revealed characteristic IBM pathology, including specific protein inclusions and inflammatory cell infiltration.
Findings:
- The patient was diagnosed with IBM co-occurring with Sjögren's syndrome.
- Treatment with corticosteroids and immunoglobulin therapy led to temporary symptom improvement.
- Macroglossia was observed alongside other IBM symptoms.
Implications:
- This case highlights a potential, previously unreported association between IBM and macroglossia.
- Macroglossia may serve as a clinical indicator for monitoring immunotherapy response in IBM patients.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
1.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.8K
Myasthenia Gravis: Diagnostic Tests
1.2K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.2K
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K

